NOV
53
-2
DFS
62
3
NKE
39
2
CI
59
-6
RHI
29
6
ECL
72
2
PFG
52
-3
NSC
64
2
CF
41
2
PH
73
3
BAX
35
3
FOXA
69
2
MA
65
-2
PYPL
31
6
OI
34
-3
BEN
29
4
SLB
55
2
DVN
28
3
RCL
76
3
MNST
59
2
NOV
53
-2
DFS
62
3
NKE
39
2
CI
59
-6
RHI
29
6
ECL
72
2
PFG
52
-3
NSC
64
2
CF
41
2
PH
73
3
BAX
35
3
FOXA
69
2
MA
65
-2
PYPL
31
6
OI
34
-3
BEN
29
4
SLB
55
2
DVN
28
3
RCL
76
3
MNST
59
2
Financhill
Back

Five9 Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
26

FIVN
Five9

Last Price:
$42.46
Seasonality Move:
7.36%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.33
Seasonality Move:
1.75%
Sell
26
Five9 (FIVN) is a Sell

Is Five9 a Buy, Sell or Hold?

  • The current Five9 [FIVN] share price is $40.12. The Score for FIVN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • FIVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FIVN Stock Price Chart

What is Five9's stock price today?

  • The Five9 share price today is $40.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FIVN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

FIVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.32 Buy
Relative Strength Index (14 RSI): 47.37 Sell
Chaikin Money Flow: -515897 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.26 - 41.7) Buy
Bollinger Bands (100): (31.34 - 42.2) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

FIVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.27 Sell
20-day SMA: 40.64 Sell
50-day SMA: 40.83 Sell
200-day SMA: 39.22 Buy
8-day EMA: 40.97 Sell
20-day EMA: 40.73 Sell
50-day EMA: 39.9 Buy
200-day EMA: 42.44 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Five9 Earnings Growth & FIVN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.38 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Five9 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):